Navigation Links
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
Date:7/17/2012

Oncology, Regulatory Bodies and Functions, France 41Figure 16: Pricing and Reimbursement in Oncology, HTA to P&R Decisions, France 42Figure 17: Pricing and Reimbursement in Oncology, Public and Private Expenditure on Health as % of Total Expenditure on Health, 2009 47Figure 18: Pricing and Reimbursement in Oncology, the UK, NHS Expenditure on Medicines ($bn) vs. NHS Medicines Cost Per Capita ($), 2000-2009 49Figure 19: Pricing and Reimbursement in Oncology, Life Expectancy at Age 65 Years, Males and Females, Japan, 2009 56

Companies Mentioned

To order this report: General Medicine and Specialty Medicine Industry: Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities

More Market Research Report

Check our Industry Analysis and Insights

__________________________
Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
2. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
3. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
4. 81,200 Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Pharmaceuticals And BioMed Realty
5. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
6. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
7. Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
8. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
9. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Ampio Pharmaceuticals Announces Proposed Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... by Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), ... Technology (Tray-style, Manifold, & Rotary) & Geography - ... MarketsandMarkets, defines and segments the lyophilization market on ... with analyses and projections of the market size ...
(Date:9/19/2014)... -- BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... ® in the U.S. and XIAPEX ® in ... , will present a corporate overview at the 21 st ... The presentation will take place on Friday, September ... Hotel in New York, NY . A ...
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
Breaking Medicine Technology:Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... (NYSE: HRC ) invites you to listen to ... Conference in New York City on February 15, 2012, at ... to the live discussion via the internet link at  http://ir.hill-rom.com/events.cfm ... recorded replay of the discussion will be available one hour ...
... growing stronger and stronger for one of the most ... on February 21-22, 2012 at the Renaissance Zurich Hotel ... 150 top pharmaceutical executives already attending, people are already ... among the industry,s influential decision makers," says conference organizer ...
Cached Medicine Technology:World's Leading Pharmaceutical Executives All Converging in Zurich, Switzerland on February 21-22, 2012 for Breakthrough Event 2
(Date:9/21/2014)... public health authorities focus on the physical activity benefits ... of Montreal reveals that for children, playing has no ... activity that is fun, done alone or with friends, ... pleasure, but also to combat boredom, sadness, fear, or ... play, authorities put aside several aspects of play that ...
(Date:9/21/2014)... PhUSE is proud to announce Dr. Pritpal Tamber, ... speakers for their 10th annual conference which is themed ... in 2013 , Charles Sabine in 2012 ... again presents high-calibre speakers to talk about relevant topics ... information. , Dr. Pritpal Tamber is a "health explorer" ...
(Date:9/21/2014)... 2014 Burnaby Physiotherapists at Absolute PhysioCare ... in order to help them with preventative care. This ... clinic that will help clients understand their problem in ... active participation in the healing process. With higher knowledge ... be able to facilitate the therapy that is initiated ...
(Date:9/21/2014)... York, NY (PRWEB) September 21, 2014 ... that help businesses and manufacturers perform tests on items ... In an increasingly regulated society, pressure on operators to ... higher than ever. A greater number of government safety ... of manufacturers' goods prior to sale. Although revenue briefly ...
(Date:9/21/2014)... September 21, 2014 Over the past ... drugs to inundate the market, thereby cutting into revenue ... industry. According to data from Industry Canada, the loss ... industry $1.8 and $2.5 billion in 2010 and 2012, ... patent exclusivity, which has hampered revenue growth, many pharmaceutical ...
Breaking Medicine News(10 mins):Health News:Narrow focus on physical activity could be ruining kids' playtime 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 2Health News:PhUSE announces Final List of Industry Influencers as Keynote Speakers 3Health News:Burnaby Physiotherapists Now Provide Educational Information for Preventative Care 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Brand Name Pharmaceutical Manufacturing in Canada Industry Market Research Report Now Available from IBISWorld 3
... A new season of Dancing With The Stars begins with new cast members and a new diet firmly in ... Nicole Scherzinger , Kate Gosselin , Shannen Doherty , new Olympic champion, Evan Lysacek , ... Jake Pavelka . , ... ...
... March 22 CCH has issued a Special Tax ... reform legislation. With the passage of the Patient Protection and ... Education Tax Credits Reconciliation Act in the House, the stage ... signing by the president to wind up the long legislative path ...
... founder of healthcare IT company, Ingenious Med, is among the more than 150 hospitalists nationwide who have earned the inaugural designation of Senior Fellow in Hospital Medicine (SFHM). , ... , ... ... ...
... psychiatric drugs. , ... , , ... ... The research was conducted by Thomson Reuters, ...
... supernatural forces are common in Ghana and other African ... witchcraft. Over thirty per cent of its inhabitants believe ... of HIV/AIDS. When meeting Ghanian colleagues, professor and ... confronted with intellectually challenging issues. "The spread ...
... Everett and Walid Saleh, a scholar of religion ... selected to receive a highly competitive New Directions Fellowship ... It is the first time the fellowships, created in ... The New Directions Fellowships are unique in ...
Cached Medicine News:Health News:The Fresh Diet Dances With The Stars Keeping the Cast in Shape and on Its Toes 2Health News:The Fresh Diet Dances With The Stars Keeping the Cast in Shape and on Its Toes 3Health News:CCH Issues Briefing on Tax Provisions of Health Care Reform Legislation 2Health News:CCH Issues Briefing on Tax Provisions of Health Care Reform Legislation 3Health News:CCH Issues Briefing on Tax Provisions of Health Care Reform Legislation 4Health News:Ingenious Med Founder, Steven Liu, Earns Senior Fellow in Hospital Medicine Designation 2Health News:Ingenious Med Founder, Steven Liu, Earns Senior Fellow in Hospital Medicine Designation 3Health News:Ingenious Med Founder, Steven Liu, Earns Senior Fellow in Hospital Medicine Designation 4Health News:Thomson Reuters Study Offers New Insight on How Physicians Prescribe Psychiatric Drugs 2Health News:Thomson Reuters Study Offers New Insight on How Physicians Prescribe Psychiatric Drugs 3Health News:Thomson Reuters Study Offers New Insight on How Physicians Prescribe Psychiatric Drugs 4Health News:Thomson Reuters Study Offers New Insight on How Physicians Prescribe Psychiatric Drugs 5Health News:Modern medicine conquers witchcraft 2Health News:Modern medicine conquers witchcraft 3Health News:Modern medicine conquers witchcraft 4Health News:University of Toronto scholars receive prestigious New Directions Fellowships 2
Albumin FS for determination of albumin in serum or plasma. For Hitachi 704 / 911. Available with Calibrator: Trucal U and Controls: Trulab N and Trulab P....
Intended for the quantitative determination of albumin in serum or plasma. Reaction: Endpoint. Wavelength: 628 nm. Linearity: 8 g/dl (80 g/l). Ready to use liquid reagent....
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
Medicine Products: